NYSE:WSTLife Sciences
Assessing West Pharmaceutical Services (WST) Valuation After Earnings Beat And Upbeat 2026 GLP 1 Guidance
West Pharmaceutical Services (WST) is back in focus after fourth quarter 2025 results beat expectations and management issued upbeat 2026 guidance, highlighting GLP-1 exposure, cash generation, and shareholder return plans.
See our latest analysis for West Pharmaceutical Services.
At a share price of $248.06, West Pharmaceutical Services has seen short term share price pressure, with a 90 day share price return of a 6.77% decline and a year to date share price return of a 10.25% decline. Even...